Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies. (Q49987358)

23 February 2018

review article

1 reference

title

Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies. (English)

1 reference

23 February 2018

dementia with Lewy bodies

main subject

dementia

0 references

1 reference

Kurt A Jellinger

1

1 reference

23 February 2018

publication date

8 December 2017

1 reference

23 February 2018

Journal of Neural Transmission

published in

1 reference

23 February 2018

https://scigraph.springernature.com/pub.10.1007/s00702-017-1821-9

exact match

0 references

cites work

The epidemiology of dementia associated with Parkinson disease

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

The epidemiology of dementia associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Are Parkinson's disease with dementia and dementia with Lewy bodies the same entity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Parkinson's disease dementia and dementia with Lewy bodies: different aspects of one entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Cognitive decline in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Hippocampal α-Synuclein in Dementia with Lewy Bodies Contributes to Memory Impairment and Is Consistent with Spread of Pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

GBA mutations in Parkinson disease: earlier death but similar neuropathological features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Amyloid-Beta Positron Emission Tomography Imaging of Alzheimer's Pathology in Parkinson's Disease Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Staging/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Impaired metabotropic glutamate receptor/phospholipase C signaling pathway in the cerebral cortex in Alzheimer's disease and dementia with Lewy bodies correlates with stage of Alzheimer's-disease-related changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Differential expression of galanin in the cholinergic basal forebrain of patients with Lewy body disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Reduction of RPT6/S8 (a Proteasome Component) and Proteasome Activity in the Cortex is Associated with Cognitive Impairment in Lewy Body Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

MRI study of caudate nucleus volume in Parkinson's disease with and without dementia with Lewy bodies and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

The cognitive profile and CSF biomarkers in dementia with Lewy bodies and Parkinson's disease dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Hippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP Type A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Impairments of speech fluency in Lewy body spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Abnormalities of cortical neural synchronization mechanisms in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

PITX3 genotype and risk of dementia in Parkinson's disease: A population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Polymorphisms in dopamine-associated genes and cognitive decline in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Tau enhances α-synuclein aggregation and toxicity in cellular models of synucleinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Cognitive impairment and resting-state network connectivity in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Differences in neuropathologic characteristics across the Lewy body dementia spectrum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Volumetric MRI study of the caudate nucleus in patients with dementia with Lewy bodies, Alzheimer's disease, and vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Review: The spectrum of clinical features seen with alpha synuclein pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Post-translational modification of α-synuclein in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

α-synuclein induced synapse damage is enhanced by amyloid-β1-42.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

New tracers and new perspectives for molecular imaging in Lewy body diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Review: Parkinson's disease: from synaptic loss to connectome dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Development of Passive Immunotherapies for Synucleinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

An Alzheimer's Disease-Derived Biomarker Signature Identifies Parkinson's Disease Patients with Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Partial loss of parvalbumin-containing hippocampal interneurons in dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Combined Analysis of CSF Tau, Aβ42, Aβ1-42% and Aβ1-40% in Alzheimer's Disease, Dementia with Lewy Bodies and Parkinson's Disease Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Cognitive decline in Parkinson's disease: the complex picture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Long-term cognitive outcome of Alzheimer's disease and dementia with Lewy bodies: dual disease is worse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Idiopathic REM sleep behaviour disorder in the development of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Arguing against the proposed definition changes of PD

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Molecular Imaging and Updated Diagnostic Criteria in Lewy Body Dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

EEG Markers of Dementia with Lewy Bodies: A Multicenter Cohort Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Comprehensive treatment of dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Structural and functional imaging study in dementia with Lewy bodies and Parkinson's disease dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Invited Article: Nervous system pathology in sporadic Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Cognitive status correlates with neuropathologic stage in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

123I-FP-CIT SPECT in the differential diagnosis between dementia with Lewy bodies and other dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Neurocognitive Deficits Distinguishing Mild Dementia with Lewy Bodies from Mild Alzheimer's Disease are Associated with Parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Imaging amyloid in Parkinson's disease dementia and dementia with Lewy bodies with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Impaired Cognition and the Risk of Parkinson Disease: Trouble in Mind

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Prying into the Prion Hypothesis for Parkinson's Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Therapeutic approaches to target alpha-synuclein pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Cross-Sectional and Longitudinal Cognitive Correlates of FDDNP PET and CSF Amyloid-β and Tau in Parkinson's Disease1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Cortical Lewy body disease and Parkinson's disease dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Brain atrophy rates in Parkinson's disease with and without dementia using serial magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Progression of white matter hyperintensities in Alzheimer disease, dementia with lewy bodies, and Parkinson disease dementia: a comparison with normal aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Medial temporal lobe atrophy on MRI differentiates Alzheimer's disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Clinical and cognitive correlates of visual hallucinations in dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Parkinson's disease is associated with hippocampal atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Copy number variation analysis of the 17q21.31 region and its role in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Changes in anatomical and functional connectivity of Parkinson's disease patients according to cognitive status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Retrospective survey of prodromal symptoms in dementia with Lewy bodies: comparison with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Primary visual cortical metabolism and rapid eye movement sleep behavior disorder in dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Clinical profiles of dementia with Lewy bodies with and without Alzheimer's disease-like hypometabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Cardiac sympathetic denervation and dementia in de novo Parkinson's disease: A 7-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Survival and dementia in GBA-associated Parkinson's disease: The mutation matters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Association of glucocerebrosidase mutations with dementia with lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

A general model of prion strains and their pathogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

The Genetic Basis of Cognitive Impairment and Dementia in Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Neuropathological correlates of dopaminergic imaging in Alzheimer's disease and Lewy body dementias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Cholinergic and perfusion brain networks in Parkinson disease dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Confluence of α-synuclein, tau, and β-amyloid pathologies in dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

MAPT H1 haplotype is associated with enhanced α-synuclein deposition in dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Synaptic phosphorylated α-synuclein in dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Lewy body cortical involvement may not always predict dementia in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Combined dementia-risk biomarkers in Parkinson's disease: a prospective longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Correlates of cerebrospinal fluid levels of oligomeric- and total-α-synuclein in premotor, motor and dementia stages of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

White matter hyperintensities, cerebrospinal amyloid-β and dementia in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Drug treatments for the neuropsychiatric complications of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Non-pharmacological interventions for Lewy body dementia: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Glucocerebrosidase mutations and neuropsychiatric phenotypes in Parkinson's disease and Lewy body dementias: Review and meta-analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Early alpha-synuclein lipoxidation in neocortex in Lewy body diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Abnormal metabotropic glutamate receptor expression and signaling in the cerebral cortex in diffuse Lewy body disease is associated with irregular alpha-synuclein/phospholipase C (PLCbeta1) interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Association Between Poor Cognitive Functioning and Risk of Incident Parkinsonism: The Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

An iTRAQ-based proteomic analysis reveals dysregulation of neocortical synaptopodin in Lewy body dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Prevalence of cerebrovascular lesions in patients with Lewy body dementia: a neuropathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Dysfunction of the locus coeruleus-norepinephrine system and related circuitry in Parkinson's disease-related dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Thalamic Involvement in Fluctuating Cognition in Dementia with Lewy Bodies: Magnetic Resonance Evidences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Lewy body dementia and Parkinson's disease with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

A new potential biomarker for dementia with Lewy bodies: Skin nerve α-synuclein deposits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Symptoms associated with Lewy body disease in mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Rapid eye movement sleep behavior disorder and subtypes in autopsy-confirmed dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Parkinson's disease dementia can be easily detected in routine clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

A clinicopathological approach to the diagnosis of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Effects of transcranial direct current stimulation upon attention and visuoperceptual function in Lewy body dementia: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

The influence of hippocampal atrophy on the cognitive phenotype of dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Alpha-synuclein gene duplication: marked intrafamilial variability in two novel pedigrees.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Clinical diagnostic criteria for dementia associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Specific patterns of neuronal loss in the pulvinar nucleus in dementia with lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Neuronal Loss and Α-Synuclein Pathology in the Superior Colliculus and Its Relationship to Visual Hallucinations in Dementia with Lewy Bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Genetic risk factors for cognitive decline in Parkinson's disease: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Accuracy of transcranial brain parenchyma sonography in the diagnosis of dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Hallucinations in Parkinson disease in the prelevodopa era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Demography, diagnostics, and medication in dementia with Lewy bodies and Parkinson's disease with dementia: data from the Swedish Dementia Quality Registry (SveDem).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Longitudinal study of cerebral blood flow SPECT in Parkinson's disease with dementia, and dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Long reaction times are associated with delayed brain activity in lewy body dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Hippocampal α-synuclein and interneurons in Parkinson's disease: Data from human and mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Amyloid imaging of Lewy body-associated disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Cholinergic and other neurotransmitter mechanisms in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Hallucinations and the spectrum of psychosis in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Incidental Lewy body disease: do some cases represent a preclinical stage of dementia with Lewy bodies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Motor performance differentiates individuals with Lewy body dementia, Parkinson's and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Validation of the neuropathologic criteria of the third consortium for dementia with Lewy bodies for prospectively diagnosed cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Glucose hypometabolism in primary visual cortex is commonly associated with clinical features of dementia with Lewy bodies regardless of cognitive conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Widespread decrease of nicotinic acetylcholine receptors in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Prevalence and clinical implication of microbleeds in dementia with lewy bodies in comparison with microbleeds in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Rapidly progressive diffuse Lewy body disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Clinical phenotype of Parkinson disease dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Dementia with Lewy Bodies: Molecular Pathology in the Frontal Cortex in Typical and Rapidly Progressive Forms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Differential diagnosis between patients with probable Alzheimer's disease, Parkinson's disease dementia, or dementia with Lewy bodies and frontotemporal dementia, behavioral variant, using quantitative electroencephalographic features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Association of a polymorphism in mitochondrial transcription factor A (TFAM) with Parkinson's disease dementia but not dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Subcortical matter in the α-synucleinopathies spectrum: an MRI pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Next-generation sequencing reveals substantial genetic contribution to dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Inverse relationship between cerebrovascular lesions and severity of lewy body pathology in patients with lewy body diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Like prions: the propagation of aggregated tau and α-synuclein in neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Effects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

The spectrum of cognitive impairment in Lewy body diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Cognitive impairment in Parkinson's disease and dementia with lewy bodies: a spectrum of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Imaging the role of amyloid in PD dementia and dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Imaging amyloid deposition in Lewy body diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

PET Radioligands Reveal the Basis of Dementia in Parkinson's Disease and Dementia with Lewy Bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Predicting Survival in Dementia With Lewy Bodies With Hippocampal Volumetry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Neuropathologic differences by race from the National Alzheimer's Coordinating Center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Duration and Pathologic Correlates of Lewy Body Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

α-synuclein genetic variability: A biomarker for dementia in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Frequency and topography of cerebral microbleeds in dementia with Lewy bodies compared to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Distinct α-synuclein strains differentially promote tau inclusions in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Parkinson's disease biomarkers: perspective from the NINDS Parkinson's Disease Biomarkers Program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

CSF biomarkers and clinical progression of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Dysfunction in attentional processing in patients with Parkinson's disease and visual hallucinations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Neuropathology underlying clinical variability in patients with synucleinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Striatal β-amyloid in dementia with Lewy bodies but not Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

The neurobiological basis of cognitive impairment in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Frontal cortical synaptophysin in Lewy body diseases: relation to Alzheimer's disease and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Patterns of atrophy in pathologically confirmed dementias: a voxelwise analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

LRRK2 variation and dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Neural correlates of visual hallucinations in dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Diffuse Lewy body disease: clinical features in nine cases without coexistent Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Pedunculopontine cholinergic cell loss in hallucinating Parkinson disease patients but not in dementia with Lewy bodies patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Distribution and Load of Amyloid-β Pathology in Parkinson Disease and Dementia with Lewy Bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

RAB39B gene mutations are not a common cause of Parkinson's disease or dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

The Prevalence and Incidence of Dementia with Lewy Bodies: a Systematic Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Medial temporal regional argyrophilic grain as a possible important factor affecting dementia in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Regional Multiple Pathology Scores Are Associated with Cognitive Decline in Lewy Body Dementias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Can we clinically diagnose dementia with Lewy bodies yet?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Usefulness of brain 99mTc-TRODAT-1 SPET for the evaluation of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Apolipoprotein E and dementia in Parkinson disease: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Cortical metabolic and nigrostriatal abnormalities associated with clinical stage-specific dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Severe Brain Metabolic Decreases Associated with REM Sleep Behavior Disorder in Dementia with Lewy Bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Cingulate island sign on FDG-PET is associated with medial temporal lobe atrophy in dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Metabolic correlate of memory-deficit awareness in dementia with Lewy bodies: Implication in cortical midline structure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled, confirmatory phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Patients homozygous and heterozygous for SNCA duplication in a family with parkinsonism and dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Neuropathologic substrates of Parkinson disease dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Significance of brain lesions in Parkinson disease dementia and Lewy body dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

The neuropathologic substrate of Parkinson disease dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Interaction between α-synuclein and tau in Parkinson's disease comment on Wills et al.: elevated tauopathy and α-synuclein pathology in postmortem Parkinson's disease brains with and without dementia. Exp Neurol 2010; 225: 210-218.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Neurobiology of cognitive impairment in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Mild cognitive impairment in Parkinson disease: heterogenous mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Prevalence and pathology of dementia with Lewy bodies in the oldest old: a comparison with other dementing disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Cerebrospinal Fluid Biomarkers of Cognitive Decline in Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

[(11)C]PIB-, [(18)F]FDG-PET and MRI imaging in patients with Parkinson's disease with and without dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Diagnostic accuracy of parkinsonism syndromes by general neurologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Striatal dopamine in Parkinson disease: A meta-analysis of imaging studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Clinical correlates of pathology in the claustrum in Parkinson's disease and dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Cerebrospinal Fluid Amyloid β1-42, Tau, and Alpha-Synuclein Predict the Heterogeneous Progression of Cognitive Dysfunction in Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Multimodality imaging characteristics of dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

AV-1451 tau and β-amyloid positron emission tomography imaging in dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Cognitive and neuropsychiatric profile of the synucleinopathies: Parkinson disease, dementia with Lewy bodies, and multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Impact of multiple pathologies on the threshold for clinically overt dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Neuropathological investigation of the hypometabolic regions on positron emission tomography with [18F] fluorodeoxyglucose in patients with dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Regional analysis and genetic association of nigrostriatal degeneration in Lewy body disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Region-specific tauopathy and synucleinopathy in brain of the alpha-synuclein overexpressing mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Relationships between age and late progression of Parkinson's disease: a clinico-pathological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Alpha-synuclein biology in Lewy body diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Cerebral Microbleeds in Patients with Dementia with Lewy Bodies and Parkinson Disease Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Cognitive and Neuroanatomical Correlates in Early Versus Late Onset Parkinson's Disease Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Meta-analysis of 123I-MIBG cardiac scintigraphy for the diagnosis of Lewy body-related disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Correlation between pathology and neuromelanin MR imaging in Parkinson's disease and dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Pathogenesis of Parkinson disease--the gut-brain axis and environmental factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Distinct brain metabolic patterns separately associated with cognition, motor function, and aging in Parkinson's disease dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Autosomal dominant Parkinson's disease caused by SNCA duplications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Parkinson's and Alzheimer's diseases: Focus on mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Can the disease course in Parkinson's disease be slowed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Disease duration and the integrity of the nigrostriatal system in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Pathologic accumulation of α-synuclein and Aβ in Parkinson disease patients with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

An antibody with high reactivity for disease-associated α-synuclein reveals extensive brain pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

21 January 2018

Autophagy in dementias

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Long-Term Cognitive Decline in Dementia with Lewy Bodies in a Large Multicenter, International Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Enhanced accumulation of phosphorylated alpha-synuclein in double transgenic mice expressing mutant beta-amyloid precursor protein and presenilin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Spreading of α-synuclein in the face of axonal transport deficits in Parkinson's disease: a speculative synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Comparing cerebral perfusion in Alzheimer's disease and Parkinson's disease dementia: an ASL-MRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

A comparative analysis of cognitive profiles and white-matter alterations using voxel-based diffusion tensor imaging between patients with Parkinson's disease dementia and dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Distinct patterns of amyloid-dependent tau accumulation in Lewy body diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

The role of high-field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Concomitant AD pathology affects clinical manifestation and survival in dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Cerebrospinal fluid biomarkers and cognitive performance in non-demented patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Biomarkers of cognitive decline in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Clinical and neuroimaging characteristics of Chinese dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Cerebrospinal α-synuclein in α-synuclein aggregation disorders: tau/α-synuclein ratio as potential biomarker for dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

The Contribution of α-Synuclein Spreading to Parkinson's Disease Synaptopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson's Disease and Lewy Body Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Neuroimaging characteristics of dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Interaction between Abeta peptide and alpha synuclein: molecular mechanisms in overlapping pathology of Alzheimer's and Parkinson's in dementia with Lewy body disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

The role of alpha-synuclein in Parkinson's disease: insights from animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Striatal and extrastriatal dopamine transporter levels relate to cognition in Lewy body diseases: an (11)C altropane positron emission tomography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson's case

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Dementia associated with Parkinson's disease: applying the Movement Disorder Society Task Force criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Neuritic degeneration in the hippocampus and amygdala in Parkinson's disease in relation to Alzheimer pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

TDP-43 pathology in Alzheimer's disease, dementia with Lewy bodies and ageing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Parkinson's disease mild cognitive impairment classifications and neurobehavioral symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Dementia with Lewy bodies and Parkinson's disease with dementia: where two worlds collide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Commentary: DLB and PDD: the same or different? Is there a debate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Dementia with Lewy bodies and Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Revisiting DLB Diagnosis: A Consideration of Prodromal DLB and of the Diagnostic Overlap With Alzheimer Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Cognitive impairment and dementia in Parkinson's disease: clinical features, diagnosis, and management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Apolipoprotein E ε4 does not affect cognitive performance in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

18F-FDG PET in Parkinsonism: Differential Diagnosis and Evaluation of Cognitive Impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Alteration of Upstream Autophagy-Related Proteins (ULK1, ULK2, Beclin1, VPS34 and AMBRA1) in Lewy Body Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

The role of levodopa in the management of dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Pretreatment Cognitive Profile Likely to Benefit from Donepezil Treatment in Dementia with Lewy Bodies: Pooled Analyses of Two Randomized Controlled Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Homovanillic acid and 5-hydroxyindole acetic acid as biomarkers for dementia with Lewy bodies and coincident Alzheimer's disease: An autopsy-confirmed study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Genetic influences on cognitive decline in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Saccadic eye movement changes in Parkinson's disease dementia and dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

The prognosis of dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Synaptic proteins and choline acetyltransferase loss in visual cortex in dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Human brain cortex: mitochondrial oxidative damage and adaptive response in Parkinson disease and in dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Low sensitivity in clinical diagnoses of dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Polymorphisms in immune/inflammatory cytokine genes are related to Parkinson's disease with cognitive impairment in the Han Chinese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Comparison of dementia with Lewy bodies to Alzheimer's disease and Parkinson's disease with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Critical appraisal of pathology transmission in the α-synuclein fibril model of Lewy body disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Genetics of Synucleinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Relationship of phosphorylated alpha-synuclein and tau accumulation to Abeta deposition in the cerebral cortex of dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

18F-FDG PET and perfusion SPECT in the diagnosis of Alzheimer and Lewy body dementias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Neuropathologic findings of dementia with lewy bodies (DLB) in a population-based Vantaa 85+ study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Functional connectivity and cognitive decline over 3 years in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

(123)I-meta-iodobenzylguanidine (MIBG) cardiac scintigraphy in α-synucleinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Hippocampal neuronal cells that accumulate α-synuclein fragments are more vulnerable to Aβ oligomer toxicity via mGluR5--implications for dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Pattern of regional cortical thinning associated with cognitive deterioration in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Minor hallucinations occur in drug-naive Parkinson's disease patients, even from the premotor phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Detection of elevated levels of soluble alpha-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Diagnostic accuracy of ¹²³I-FP-CIT (DaTSCAN) in dementia with Lewy bodies: a meta-analysis of published studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Dementia with Lewy Bodies versus Alzheimer's Disease and Parkinson's Disease Dementia: A Comparison of Cognitive Profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Phenotypic differences based on staging of Alzheimer's neuropathology in autopsy-confirmed dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Natural course of mild cognitive impairment in Parkinson disease: A 5-year population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Resting state in Parkinson's disease dementia and dementia with Lewy bodies: commonalities and differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Cerebral metabolic dysfunction in patients with dementia with Lewy bodies and visual hallucinations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Aβ-amyloid deposition in patients with Parkinson disease at risk for development of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Amyloid deposition in Parkinson's disease and cognitive impairment: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Genome-wide association study of neocortical Lewy-related pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Gene expression profiling of brain samples from patients with Lewy body dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Aβ deposition is associated with enhanced cortical α-synuclein lesions in Lewy body diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

The New Diagnostic Criteria for Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

MDS clinical diagnostic criteria for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Neuroanatomical changes in Parkinson's disease in relation to cognition: An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

123I-metaiodobenzylguanidine scintigraphy in Parkinson's disease and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Default mode network and extrastriate visual resting state network in patients with Parkinson's disease dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Grey matter changes in cognitively impaired Parkinson's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Review: Spreading the word: precise animal models and validated methods are vital when evaluating prion-like behaviour of alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Parkinson's disease and dementia with Lewy bodies: one disease or two?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Accuracy of clinical diagnosis of Parkinson disease: A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Accuracy of clinical diagnosis of dementia with Lewy bodies: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Shared and Distinct Patterns of Oligodendroglial Response in α-Synucleinopathies and Tauopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Brain perfusion in dementia with Lewy bodies and Alzheimer's disease: an arterial spin labeling MRI study on prodromal and mild dementia stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

LIMP-2 expression is critical for β-glucocerebrosidase activity and α-synuclein clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Cortical Lewy bodies and Aβ burden are associated with prevalence and timing of dementia in Lewy body diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Prodromal Dementia with Lewy Bodies and Prodromal Alzheimer's Disease: A Comparison of the Cognitive and Clinical Profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Diagnosis of dementia with Lewy bodies: can 123I-IMP and 123I-MIBG scintigraphy yield new core features?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Correlations between gray matter reductions and cognitive deficits in dementia with Lewy Bodies and Parkinson's disease with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Transcriptional network analysis in frontal cortex in Lewy body diseases with focus on dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Amyloid-β deposition and regional grey matter atrophy rates in dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Incidence of dementia with Lewy bodies and Parkinson disease dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Survival and Causes of Death Among People With Clinically Diagnosed Synucleinopathies With Parkinsonism: A Population-Based Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

First-in-human assessment of PRX002, an anti-α-synuclein monoclonal antibody, in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Active immunization therapies for Parkinson's disease and multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Neuropathology of genetic synucleinopathies with parkinsonism: Review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

A pathologic cascade leading to synaptic dysfunction in alpha-synuclein-induced neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Interregional correlations in Parkinson disease and Parkinson-related dementia with resting functional MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

The brainstem pathologies of Parkinson's disease and dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

A clinico-pathological study of subtypes in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Dementia risk in Parkinson disease: disentangling the role of MAPT haplotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Mechanisms of orthostatic hypotension and supine hypertension in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Cortical serotonin 1A receptor levels are associated with depression in patients with dementia with Lewy bodies and Parkinson's disease dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Correlation between clinical symptoms and striatal DAT uptake in patients with DLB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

High Frequency of GBA Gene Mutations in Dementia With Lewy Bodies Among Ashkenazi Jews

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Loss of Dopamine Transporter Binding and Clinical Symptoms in Dementia With Lewy Bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Genome-wide association study reveals genetic risk underlying Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

The utility of α-synuclein as biofluid marker in neurodegenerative diseases: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Associations between Cerebrospinal Fluid Biomarkers and Cognition in Early Untreated Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Accuracy of Clinical Diagnosis of Dementia with Lewy Bodies versus Neuropathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Initial neuropsychological impairments in patients with the E46K mutation of the α-synuclein gene (PARK 1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Pathological correlates of dementia in a longitudinal, population-based sample of aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Anti-α-synuclein immunotherapy reduces α-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Interactions of pathological proteins in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Amyloid-β and α-synuclein cerebrospinal fluid biomarkers and cognition in early Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-Analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Treatment effect of memantine on survival in dementia with Lewy bodies and Parkinson's disease with dementia: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson's disease and dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Evaluating the relationship between amyloid-β and α-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Exploring the Phenotype in Mild Cognitive Impairment to Aid the Prediction of Those at Risk of Transitioning to Parkinson Disease and Dementia With Lewy Bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Different Clinical and Neuroimaging Characteristics in Early Stage Parkinson's Disease with Dementia and Dementia with Lewy Bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Alteration of autophagosomal proteins (LC3, GABARAP and GATE-16) in Lewy body disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

A practical approach to remote longitudinal follow-up of Parkinson's disease: the FOUND study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Population-based analysis of pathological correlates of dementia in the oldest old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

CSF β-Amyloid 1-42 Predicts Progression to Cognitive Impairment in Newly Diagnosed Parkinson Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Clinicians' ability to diagnose dementia with Lewy bodies is not affected by β-amyloid load

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

(123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A compa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Pathological α-synuclein distribution in subjects with coincident Alzheimer's and Lewy body pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

APOE ε4 increases risk for dementia in pure synucleinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Dementia with Lewy bodies and Parkinson's disease with dementia: are they different?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Neuropathology of dementia with Lewy bodies in advanced age: a comparison with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

An order in Lewy body disorders: Retrograde degeneration in hyperbranching axons as a fundamental structural template accounting for focal/multifocal Lewy body disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Combination therapies: The next logical Step for the treatment of synucleinopathies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

[(123)]FP-CIT SPECT scans initially rated as normal became abnormal over time in patients with probable dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Fluctuating cognition and different cognitive and behavioural profiles in Parkinson's disease with dementia: comparison of dementia with Lewy bodies and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

An update on the genetics of dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

In vivo assessment of vesicular monoamine transporter type 2 in dementia with lewy bodies and Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Tau protein, beta-amyloid₁₋₄₂ and clusterin CSF levels in the differential diagnosis of Parkinsonian syndrome with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Neurodegenerative diseases: expanding the prion concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: a comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Comparison of cognitive decline between dementia with Lewy bodies and Alzheimer's disease: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Evolution of clinical features in possible DLB depending on FP-CIT SPECT result.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Sonographic discrimination of dementia with Lewy bodies and Parkinson's disease with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

TREM2 p.R47H substitution is not associated with dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Synthesis and biological evaluation of novel radioiodinated benzimidazole derivatives for imaging α-synuclein aggregates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Magnetic resonance imaging in lewy body dementias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Patterns of gray matter atrophy in dementia with Lewy bodies: a voxel-based morphometry study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Current concepts and controversies in the pathogenesis of Parkinson's disease dementia and Dementia with Lewy Bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Increased CSF neurogranin concentration is specific to Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Cerebrospinal fluid levels of IL-6 are decreased and correlate with cognitive status in DLB patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

18F-FDG PET in Posterior Cortical Atrophy and Dementia with Lewy Bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer's and Lewy body pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Convergence of pathology in dementia with Lewy bodies and Alzheimer's disease: a role for the novel interaction of alpha-synuclein and presenilin 1 in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Investigation of Lewy pathology in the visual pathway of brains of dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Posterior Ventricular Enlargement to Differentiate Dementia with Lewy Bodies from Alzheimer's Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

The mild cognitive impairment stage of dementia with Lewy bodies and Parkinson disease: a comparison of cognitive profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Diagnostic accuracy of 123I-meta-iodobenzylguanidine myocardial scintigraphy in dementia with Lewy bodies: a multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Early neuropsychological discriminants for Lewy body disease: an autopsy series

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Neuropsychological profile in patients with early stage of Parkinson's disease in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

The prevalence of dementia with Lewy bodies in a rural area of China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Patterns and stages of alpha-synucleinopathy: Relevance in a population-based cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Prevalence of Dementia With Lewy Body Symptoms: A Cross-Sectional Study in 40 Swedish Nursing Homes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Cortical thinning is associated with disease stages and dementia in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

The locus ceruleus and dementia in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

A comparison of gray and white matter density in patients with Parkinson's disease dementia and dementia with Lewy bodies using voxel-based morphometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-017-1821-9

Dementia with Lewy bodies: prevalence, clinical spectrum and natural history

21 January 2018

1 reference

12 December 2020

Cortical Lewy body pathology in the diagnosis of dementia.

1 reference

12 December 2020

Recent advances in the understanding of the role of synaptic proteins in Alzheimer's Disease and other neurodegenerative disorders

1 reference

12 December 2020

Dementia with Lewy bodies from the perspective of tauopathy

1 reference

12 December 2020

Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias

1 reference

12 December 2020

Pathological substrate of dementia in Parkinson's disease--its relation to DLB and DLBD

1 reference

12 December 2020

Parkinson's disease-related visual hallucinations unresponsive to atypical antipsychotics treated with cholinesterase inhibitors: a case series

1 reference

12 December 2020

Association of visual hallucinations with reduction of MIBG cardiac uptake in Parkinson's disease

1 reference

12 December 2020

Predictors of survival in dementia with lewy bodies and Parkinson dementia

1 reference

12 December 2020

Morphological substrates of parkinsonism with and without dementia: a retrospective clinico-pathological study.

1 reference

12 December 2020

Cortical alpha-synuclein load is associated with amyloid-beta plaque burden in a subset of Parkinson's disease patients

1 reference

12 December 2020

Re: In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution

1 reference

12 December 2020

Visual object recognition and attention in Parkinson's disease patients with visual hallucinations.

1 reference

12 December 2020

Parkinson's disease dementia: definitions, guidelines, and research perspectives in diagnosis

1 reference

12 December 2020

A comparison of gray and white matter density in patients with Parkinson's disease dementia and dementia with Lewy bodies using voxel-based morphometry

1 reference

12 December 2020

Cognitive impairment and dementia in Parkinson's disease

1 reference

12 December 2020

Striatal Aβ peptide deposition mirrors dementia and differentiates DLB and PDD from other parkinsonian syndromes

1 reference

12 December 2020

Glucocerebrosidase mutations confer a greater risk of dementia during Parkinson's disease course

1 reference

12 December 2020

Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease

1 reference

12 December 2020

Identification of biomarkers in Lewy-body disorders

1 reference

12 December 2020

[The clinical significance of MIBG myocardial scintigraphy in Parkinson disease].

1 reference

12 December 2020

Low-abundant cerebrospinal fluid proteome alterations in dementia with Lewy bodies

1 reference

12 December 2020

Comparison of quantitative EEG between patients with Alzheimer's disease and those with Parkinson's disease dementia

1 reference

12 December 2020

Mapping cortical atrophy in Parkinson's disease patients with dementia

1 reference

12 December 2020

Low levels of soluble NG2 in cerebrospinal fluid from patients with dementia with Lewy bodies.

1 reference

12 December 2020

Large-scale resting state network correlates of cognitive impairment in Parkinson's disease and related dopaminergic deficits.

1 reference

12 December 2020

Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies

1 reference

12 December 2020

Neurodegeneration and cognition in Parkinson's disease: a review.

1 reference

12 December 2020

The Diagnostic and Differential Diagnosis Utility of Cerebrospinal Fluid α -Synuclein Levels in Parkinson's Disease: A Meta-Analysis

1 reference

12 December 2020

Disease-modifying therapeutic directions for Lewy-Body dementias

1 reference

12 December 2020

Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases

1 reference

12 December 2020

Lewy Body Dementias: Dementia With Lewy Bodies and Parkinson Disease Dementia

1 reference

12 December 2020

Alzheimer's disease pathology in synucleinopathies

1 reference

12 December 2020

Neuropathological Staging of Brain Pathology in Sporadic Parkinson's disease: Separating the Wheat from the Chaff

1 reference

12 December 2020

Regional Overlap of Pathologies in Lewy Body Disorders.

1 reference

12 December 2020

Synaptic proteins in CSF relate to Parkinson's disease stage markers

1 reference

12 December 2020

Dementia with Lewy Bodies and Parkinson Disease Dementia: It is the Same Disease!

1 reference

12 December 2020

Author response: Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB

1 reference

12 December 2020

Parkinson's disease susceptibility variants and severity of Lewy body pathology.

1 reference

12 December 2020

The heart of PD: Lewy body diseases as neurocardiologic disorders.

1 reference

12 December 2020

Cognitive and behavioral disorders in Parkinson's disease: an update. II: behavioral disorders.

1 reference

12 December 2020

Cognitive and behavioral disorders in Parkinson's disease: an update. I: cognitive impairments.

1 reference

12 December 2020

Does attentional dysfunction and thalamic atrophy predict decline in dementia with Lewy bodies?

1 reference

12 December 2020

Propagation of alpha-synuclein pathology from the olfactory bulb: possible role in the pathogenesis of dementia with Lewy bodies.

1 reference

12 December 2020

Synaptic markers of cognitive decline in neurodegenerative diseases: a proteomic approach.

1 reference

12 December 2020

White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson's disease with dementia, and Alzheimer's disease.

1 reference

12 December 2020

Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?

1 reference

12 December 2020

10.1007/S00702-017-1821-9

Identifiers

DOI

1 reference

23 February 2018

PubMed ID

29222591

1 reference

23 February 2018